ERBB2 and triple-negative breast carcinoma: We used several breast cancer cell lines (MDA-MB-468, BT-549, MDA-MB-231, CAL120 and HCC1395) originating from patients with triple-negative breast cancer (TNBC; negative for estrogen and progesterone receptors and HER2).